Delving into the Latest Updates on Mesenchymal stem cell transplantation(Assiut University) with Synapse

Overview

Basic Info

Drug Type

Mesenchymal stem cell therapy

Synonyms-

Target-

Action-

Mechanism

Cell replacements

Therapeutic Areas-

Active Indication-

Inactive Indication-

Originator Organization

Assiut University

Active Organization-

Inactive Organization-

License Organization-

Drug Highest Phase-

First Approval Date-

Regulation-

Comparing different lines of treatment of Duchenne Myopathy (DM) and assessment of new lines of treatment (mesenchymal stem cell, phosphodiesterase inhibitors) in reducing the impact of disability in the patients with Duchenne Myopathy and slowing the progression of cardiomyopathy
Upsetting and implementation of the best treatment plan for those children with Duchenne myopathy which is suitable for the available resources in Assiut University Children Hospital

Start Date01 Sep 2018

Sponsor / Collaborator

Assiut University

100 Clinical Results associated with Mesenchymal stem cell transplantation(Assiut University)

Login to view more data

100 Translational Medicine associated with Mesenchymal stem cell transplantation(Assiut University)

Login to view more data

100 Patents (Medical) associated with Mesenchymal stem cell transplantation(Assiut University)

Login to view more data

100 Deals associated with Mesenchymal stem cell transplantation(Assiut University)

Login to view more data